```html

Granuloma (Skin)

What is Granuloma (skin)?

A skin granuloma is a small, localized nodule formed when the immune system walls off substances it perceives as foreign but cannot eliminate. The wall‑off reaction consists of clusters of specialized immune cells—macrophages, epithelioid cells, and often multinucleated giant cells—surrounded by lymphocytes and fibroblasts. Although the term “granuloma” describes the microscopic pattern, clinically it appears as a firm, sometimes raised bump that can be pink, reddish‑brown, or flesh‑colored.

Granulomas are not a disease themselves; they are a reaction pattern that can arise in many dermatologic and systemic conditions. Understanding the underlying cause is essential because the treatment and prognosis differ widely.

Sources: Mayo Clinic; National Institute of Allergy and Infectious Diseases (NIAID); American Academy of Dermatology (AAD).

Common Causes

Below are the most frequently encountered conditions that can produce skin granulomas. Some are benign and self‑limited, while others may indicate systemic disease.

• Infectious agents
  • Mycobacterium tuberculosis (tuberculous granuloma)
  • Non‑tuberculous mycobacteria (e.g., M. chelonae, M. fortuitum)
  • Fungal organisms (e.g., Histoplasma, Blastomyces)
  • Leishmania parasite (cutaneous leishmaniasis)
  • Cutaneous sarcoidosis (often sterile but granulomatous)
• Foreign‑body reactions
  • Suture material or surgical mesh
  • Glass, splinters, or tattoo ink
  • Silicone injections or implants
• Inflammatory dermatoses
  • Granuloma annulare (most common benign form)
  • Lupus erythematosus profundus
  • Granulomatous rosacea
• Vascular or neoplastic conditions
  • Pyogenic granuloma (lobular capillary hemangioma)
  • Dermatofibroma with granulomatous features
• Drug‑induced reactions
  • Immune checkpoint inhibitors
  • Biologic agents for psoriasis or rheumatoid arthritis

Associated Symptoms

The presence of a skin granuloma may be isolated, but many patients notice additional signs that help point toward the underlying cause.

• Pain or tenderness at the nodule (more common with infection or pyogenic granuloma)
• Itching (pruritus) especially in granuloma annulare or rosacea
• Redness (erythema) or swelling surrounding the lesion
• Ulceration or drainage of pus if the granuloma becomes secondarily infected
• Multiple lesions in a symmetric distribution (typical of granuloma annulare)
• Systemic symptoms such as fever, night sweats, weight loss (suggestive of tuberculosis, sarcoidosis, or deep fungal disease)
• Respiratory or joint symptoms when the granuloma is part of a systemic disease (e.g., sarcoidosis affecting lungs, rheumatoid arthritis on biologics)

When to See a Doctor

Most skin granulomas are not emergencies, yet early evaluation can prevent complications and uncover hidden systemic illness. You should schedule a medical appointment if you notice:

• A new lump that enlarges rapidly (more than 1 cm in a few weeks)
• Pain, warmth, or increasing redness that suggests infection
• Persistent itching or burning that does not improve with over‑the‑counter creams
• Bleeding or drainage from the lesion
• Multiple lesions appearing suddenly, especially after a skin injury or tattoo
• Associated systemic symptoms (fever, cough, shortness of breath, joint swelling)
• Any lesion that changes color, shape, or texture after being monitored for 4–6 weeks

Diagnosis

Accurate diagnosis relies on a combination of clinical assessment and targeted investigations.

1. Clinical History & Physical Examination

• Onset, growth pattern, and any preceding trauma or exposure
• Medication list (including over‑the‑counter and herbal products)
• Travel history, occupational exposures, and animal contacts
• Full skin exam to look for additional lesions

2. Dermatoscopy

Handheld magnification can reveal characteristic vascular patterns in pyogenic granuloma or annular arrangements in granuloma annulare.

3. Skin Biopsy

Standard of care for any persistent or atypical granuloma.

• Punch or excisional biopsy provides tissue for histopathology.
• Special stains (Ziehl‑Neelsen for acid‑fast bacilli, PAS or GMS for fungi) help identify infectious agents.
• Immunohistochemistry may be needed for sarcoidosis or lymphoma.

4. Laboratory Tests (when indicated)

• Complete blood count (CBC) and inflammatory markers (ESR, CRP)
• Serum calcium and ACE level (elevated in sarcoidosis)
• Quantiferon‑TB Gold or TB skin test if tuberculosis is suspected
• Serology for leishmaniasis in travelers to endemic regions

5. Imaging

Chest X‑ray or CT scan is performed when systemic sarcoidosis or disseminated mycobacterial infection is in the differential diagnosis.

Treatment Options

Treatment is tailored to the underlying cause and the lesion’s impact on function or aesthetics.

1. Infection‑Related Granulomas

• Antibiotics or antitubercular therapy – guided by culture, sensitivity, or PCR results.
• Antifungal agents – itraconazole, fluconazole, or amphotericin B for deep fungal infections.
• Adjunctive wound care: gentle cleaning, sterile dressings, and monitoring for secondary bacterial infection.

2. Granuloma Annulare

• Topical corticosteroids or calcineurin inhibitors for localized lesions.
• Intralesional triamcinolone for deeper plaques.
• Systemic options (hydroxychloroquine, dapsone, niacinamide) for extensive disease.
• Observation—many cases resolve spontaneously within 2‑5 years.

3. Pyogenic Granuloma

• Physical removal: curettage, shave excision, or laser ablation.
• Topical silver nitrate or imiquimod to promote regression.
• Electrodessication & curettage (EDC) – highly effective with low recurrence.

4. Sarcoidosis‑Related Granulomas

• Observation for asymptomatic skin lesions.
• Topical or intralesional steroids for cosmetic concerns.
• Systemic therapy (prednisone, methotrexate, or TNF‑α inhibitors) if multi‑organ involvement is present.

5. Foreign‑Body Granulomas

• Surgical excision of the offending material when feasible.
• Topical anti‑inflammatory agents to reduce residual inflammation.

6. General Home Care

• Keep the area clean; use mild soap and water.
• Avoid picking or scratching—this can introduce bacteria.
• Apply a thin layer of over‑the‑counter hydrocortisone 1 % for mild itching.
• Use sun protection; UV exposure can worsen certain granulomatous dermatoses.

All treatment plans should be discussed with a dermatologist or primary‑care physician familiar with the specific cause.

Prevention Tips

While some granulomas are unavoidable, many can be prevented by minimizing skin injury and controlling systemic risk factors.

• Practice good wound hygiene—clean cuts promptly and keep them covered.
• Avoid inserting non‑sterile objects under the skin (e.g., unregulated tattoos, piercings).
• Follow infection‑control measures when traveling to endemic regions (use insect repellent, wear protective clothing).
• Maintain up‑to‑date vaccinations, especially BCG in countries where tuberculosis is prevalent.
• Discuss medication side‑effects with your physician; some biologics may require regular skin monitoring.
• Manage chronic diseases such as diabetes, which can impair healing and predispose to infections.

Emergency Warning Signs

If any of the following occur, seek immediate medical attention (e.g., go to the nearest emergency department or call 911):

• Rapid swelling of the lesion accompanied by severe pain, warmth, or a fever >100.4 °F (38 °C) – possible cellulitis or abscess.
• Sudden onset of heavy bleeding that does not stop with gentle pressure.
• Signs of an allergic reaction after a new medication or topical product (hives, swelling of lips/tongue, difficulty breathing).
• Neurological symptoms (numbness, weakness) in the area of a large granuloma—rare but may indicate nerve involvement.
• Rapidly enlarging ulcerated lesion with foul odor—suggests aggressive infection needing IV antibiotics.

---

References: Mayo Clinic. “Granuloma Annulare.” 2023; CDC. “Tuberculosis (TB).” 2022; National Institute of Health (NIH) – National Library of Medicine. “Sarcoidosis.” 2021; American Academy of Dermatology. “Skin Biopsy Guidelines.” 2022; WHO. “Leishmaniasis Fact Sheet.” 2023.

```